BlackRock Institutional Trust’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$18.7M Buy
382,051
+15,772
+4% +$772K ﹤0.01% 2013
2016
Q3
$17.5M Buy
366,279
+3,718
+1% +$178K ﹤0.01% 1972
2016
Q2
$19.5M Sell
362,561
-18,492
-5% -$992K ﹤0.01% 1862
2016
Q1
$17M Buy
381,053
+302
+0.1% +$13.5K ﹤0.01% 1920
2015
Q4
$14.5M Sell
380,751
-14,652
-4% -$559K ﹤0.01% 2080
2015
Q3
$12.6M Sell
395,403
-102,454
-21% -$3.26M ﹤0.01% 2130
2015
Q2
$16.4M Sell
497,857
-33,243
-6% -$1.1M ﹤0.01% 2060
2015
Q1
$21.9M Sell
531,100
-12,799
-2% -$527K ﹤0.01% 1870
2014
Q4
$22.2M Buy
543,899
+12,420
+2% +$506K ﹤0.01% 1834
2014
Q3
$19.5M Buy
531,479
+56,615
+12% +$2.08M ﹤0.01% 1885
2014
Q2
$22M Sell
474,864
-32,900
-6% -$1.52M ﹤0.01% 1891
2014
Q1
$20.9M Buy
507,764
+118,231
+30% +$4.86M ﹤0.01% 1925
2013
Q4
$14.9M Buy
389,533
+3,465
+0.9% +$132K ﹤0.01% 2146
2013
Q3
$9.22M Buy
386,068
+7,743
+2% +$185K ﹤0.01% 2409
2013
Q2
$6.43M Buy
+378,325
New +$6.43M ﹤0.01% 2573